1-4 of 4
Robert Smith
Close
Sort by
Journal Articles

Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma

Samer Al Hadidi, Obada Ababneh, Carson W Ercanbrack, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Guido Tricot, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Maurizio Zangari, Frits van Rhee
Journal: Blood
Blood (2023) 142 (Supplement 1): 3594.
https://doi.org/10.1182/blood-2023-181034
Published: 2023
Journal Articles

EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab

Frits van Rhee, MD PhD, Sharmilan Thanendrarajan, MD, Carolina D. Schinke, MD, Jeffery R. Sawyer, Adam Rosenthal, MS, Doug Steward, Phil Farmer, Robert Smith, Milan Bimali, PhD, Mariam M. Boota, MD, Clyde Bailey, Brian A Walker, PhD, Antje Hoering, PhD, Gareth Morgan, MD PhD, Maurizio Zangari, MD, Faith E. Davies, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4569.
https://doi.org/10.1182/blood-2019-131887
Published: 2019
Journal Articles

Depletion of Host CD122 + Cells Facilitates Widespread Skeletal Multiple Myeloma Engraftment in NOD/SCID Recipients

Lisa M Freeman, Eugene Petcu, Robert Smith, Ali Salajegheh, Peter Diamond, Andrew Christopher William Zannettino, BSc, PhD, Andreas Evdokiou, John Luff, Dalia Khalil, Frank Vari, Lawrence Catley, MD, Derek Hart, PhD, Slavica Vuckovic
Journal: Blood
Blood (2008) 112 (11): 2734.
https://doi.org/10.1182/blood.V112.11.2734.2734
Published: 2008
Journal Articles

Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis

Sandra H. P. Oliveira, Dennis D. Taub, James Nagel, Robert Smith, Cory M. Hogaboam, Aaron Berlin, Nicholas W. Lukacs
Journal: Blood
Blood (2002) 100 (13): 4291–4297.
https://doi.org/10.1182/blood.V100.13.4291
Published: 2002